Alastin Skincare, A Galderma Company, specializes in creating advanced skincare solutions that are designed to correct, protect, and sustain healthy skin for a lifetime. Their unmatched procedure enhancement products are crafted with the latest technology and are rigorously tested to ensure both safety and effectiveness in revitalizing the skin’s youthful functions.
Founded in 2015 and headquartered in Carlsbad, California, the company has established itself as a leader in the skincare industry.
The company recently received a significant $9.88M Venture Round investment at 22 February 2019 from Tigris Ventures.
Alastin Skincare operates in the Biotechnology and Health Care industries, which are both experiencing rapid growth and increasing demand for innovative solutions. The company’s focus on both corrective and protective skincare positions it well in a market that values scientifically validated products.
As a venture capital investor, the company’s focus on technology-driven skincare solutions, along with its successful track record and recent investment from Tigris Ventures, demonstrates compelling potential for long-term growth and innovation in the skincare industry.
Alastin Skincare’s commitment to safety, efficacy, and innovation aligns with current market trends and consumer demands, making it an attractive investment opportunity in the rapidly expanding skincare market.
No recent news or press coverage available for Alastin Skincare, A Galderma Company.